Li Ka Shing Faculty of Medicine

The Li Ka Shing Faculty of Medicine at the University of Hong Kong is a leading medical institution currently making significant advancements in public health and emergency medicine. Recently, the faculty launched the city's first community pharmacist-led osteoporosis screening program, aiming to identify individuals at high risk and prevent bone fractures. This initiative underscores their commitment to proactive healthcare within the community. Furthermore, researchers from the faculty have developed a groundbreaking nasal spray designed for rapid first aid in ischemic stroke cases. This innovative treatment, which delivers therapeutic powder directly to the brain, is slated for clinical trials by 2030 and holds the potential to revolutionize emergency stroke care. These developments highlight the faculty's ongoing dedication to pioneering medical research and implementing practical solutions for pressing health challenges in Hong Kong and beyond.